Innovative Therapies forum focuses on topics across wound care settings, surgical disciplines

NewsGuard 100/100 Score
Modern Negative Pressure Wound Therapy (NPWT) has been in practice since the late 1970's when plastic surgeon Dr. Paul Svedman began treating patients. It is estimated that over half a million patients in the United States receive NPWT every year, but that millions more would benefit from the therapy if it were more accessible. New treatment options are critical to continue advancement of the field to save patients with chronic suffering of open wounds. An elite group of surgeons and ITI's executive team met in a forum to discuss the future of NPWT and how the needs of patients in various areas of wound care might be optimized. Mr. Richard Vogel, CEO of ITI, (, stated "It is imperative that we work in concert with surgeons specialized in the field of NPWT, as there is much unmet need and patients could greatly benefit from further advances in this technology." The forum focused on scientifically advanced topics across wound care settings and across surgical disciplines. The group concluded that more clinical research will be required to further the discussions shared within this forum. 

Dr. Michael Kulick, a San Francisco plastic surgeon, stated that "To have this type of medical forum that combines ideas across several surgical specialties was unique and much more forward thinking than what has occurred in the past. This provided us the venue for scientific exchange to further NPWT in our medical practices."

This was the first of many scientific forums that ITI will be supporting as part of its continuing effort to advance the state-of-the-art of NPWT.


Innovative Therapies Inc


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel antibiotic-infused hydrogel kills bacteria and promotes cell growth